Name: Latest research reports of Laurus Labs Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Laurus Labs Ltd.
Rating: 1
Author: BOB Capital Markets Ltd.

Laurus Labs Ltd.

NSE: LAURUSLABS | BSE: 540222 | ISIN: INE947Q01028 | Industry: Pharmaceuticals
| Mid-range Performer

966.3500 -19.15 (-1.94%)

NSE Feb 10, 2026 15:31 PM

88.61% Gain from 52W Low

Volume: 1.2M

Laurus Labs Ltd.

25 Jan 2024

966.35

-1.94%

Laurus Labs (SELL): Challenges galore cut to SELL

Sell: Laurus Labs Ltd.

Recommendation Target

BOB Capital Markets Ltd.

Fourth straight quarterly miss with upsets on all fronts; Q3 revenue/ EBITDA well short of Bloomberg consensus by 13%/79%

Laurus Labs Ltd. is trading below its 30 day SMA of 1032.3